Inter Venn Biosciences
Biotechnology, 800 Chesapeake Dr, South San Francisco, California, 94063, United States, 51-200 Employees
Who is INTERVENN BIOSCIENCES
InterVenn was co-founded by Nobel Laureate Dr. Carolyn Bertozzi, world-class scientist, and distinguished professor Dr. Carlito Lebrilla and leading AI/ML expert Aldo Carrascoso on the be...
Read More
-
Headquarters: 800 Chesapeake Dr, South San Francisco, California, 94063, United States
-
Date Founded: 2017
-
Employees: 51-200
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from INTERVENN BIOSCIENCES
InterVenn Biosciences Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding InterVenn Biosciences
Answer: InterVenn Biosciences's headquarters are located at 800 Chesapeake Dr, South San Francisco, California, 94063, United States
Answer: InterVenn Biosciences's official website is https://intervenn.bio
Answer: InterVenn Biosciences's revenue is $10 Million to $25 Million
Answer: InterVenn Biosciences's SIC: 2836
Answer: InterVenn Biosciences's NAICS: 541714
Answer: InterVenn Biosciences has 51-200 employees
Answer: InterVenn Biosciences is in Biotechnology
Answer: InterVenn Biosciences contact info: Phone number: Website: https://intervenn.bio
Answer: InterVenn was co-founded by Nobel Laureate Dr. Carolyn Bertozzi, world-class scientist, and distinguished professor Dr. Carlito Lebrilla and leading AI/ML expert Aldo Carrascoso on the belief that no one should ever be blindsided by disease. We are focused on decoding the glycoproteome as a rich source of biological insight. Thanks to the use of artificial intelligence (AI), we have pioneered a proprietary technology platform, GlycoVisionTM, to tap into this layer of biology at a clinically meaningful scale. GlycoVision is capable of producing a robust pipeline of powerful clinical applications, ranging from early disease screening to diagnostics and potentially therapeutics. The GlycoVision platform is accessible to industry partners seeking to discover novel biomarkers from as little as 50 L of serum or plasma.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month